Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Burden on Patients: Two Steps Forward and One Step Back for HIV/AIDS Patients

By Allyson Funk  |    June 25, 2014
It was only a few decades ago that an HIV/AIDS diagnosis was a death sentence. Since the development of breakthrough treatments for patients living with HIV or AIDS, the death rate has decreased more...   Read More

Burden on Patients: Preserving the ‘New Normal’ for Patients with Rheumatoid Arthritis

By Allyson Funk  |    June 24, 2014
In the last 20 years, medical advances have transformed the lives of Rheumatoid Arthritis (RA) patients. Instead of managing symptoms, innovative medicines help slow disease progression and can even...   Read More

Understanding Health Insurance Exchanges State-by-State

By Allyson Funk  |    June 19, 2014
It’s no secret that when it comes to the Affordable Care Act, health insurance exchange coverage varies depending on where you live. From the plans offered, to premiums, to the type of Marketplace, ...   Read More

More than 430 Medicines in Development to Treat Chronic Diseases Affecting Older Americans

By Robert Zirkelbach  |    June 18, 2014
Aging is a fact of life but the good news is that life expectancy continues to climb and more and more Americans are living fuller, richer lives thanks in large part to innovative medicines being...   Read More

Working Together for the Greater Good: The Current State of the Collaborative Research Ecosystem in Oncology

By John Castellani  |    June 14, 2014
Keeping the spirit of innovation alive in the oncology field is paramount to future scientific advances and finding cures. An essential element of innovation is collaboration. Relevant stakeholders...   Read More

High Cost of Medicines in Health Insurance Exchange Plans Is Harming Patients

By Robert Zirkelbach  |    June 12, 2014
PhRMA President and CEO John J. Castellani recently joined several patient organizations to raise concerns about patients’ access to medicines in the new health insurance exchanges.  They discussed...   Read More

Some Health Insurance Exchange Plans Put All Treatments for Certain Diseases on Top Cost-Sharing Tier

By Allyson Funk  |    June 11, 2014
This morning at the National Press Club, PhRMA CEO John J. Castellani joined patient groups to release new research from Avalere Health. Following reports that patients with health insurance exchange...   Read More

Are Health Insurance Exchange Cost-Sharing Reductions Really Helping Low-Income Patients Access Medicines?

By Allyson Funk  |    June 3, 2014
Ensuring that patients have access to the medicines they need is at the heart of what biopharmaceutical research companies do every day. The Affordable Care Act put in place a new way for Americans...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates